InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,541.09
(
0.53%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

QyQ

Send PM Follow Ignore
Followers 0
Posts 61
Boards Moderated 0
Alias Born 04/13/2013

QyQ

Re: Just the facts maam post# 25330

Tuesday, 04/16/2013 3:17:12 PM

Tuesday, April 16, 2013 3:17:12 PM

Post# of 26138
JTFM,

Most of the press stated ANI reportedly had revenue of around $16 million for 2011. I believe this revenue is valid for 2011. I read somewhere also stated ANI reported $21m revenue up to Sep 2012. Should close at $23m max for 2012 (my estimation)

'Right now, BioSante is valued the way Wall Street says,” Simes says in an interview with Minyanville. “We did the best deal for shareholders.'

http://www.minyanville.com/sectors/biotech-pharma/articles/biosante-stephen-simes-ani-pharmaceuticals-libigel/10/4/2012/id/44700?camp=syndication&medium=portals&from=yahoo
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up